Effects of Nattokinase on Inflammation and Cardiovascular Risk Markers in Patients With Dyslipidemia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The study aims to evaluate the effect of the nattokinase enzyme on inflammation and markers of cardiovascular risk in participants with dyslipidemia. A longitudinal double-blind randomized clinical trial will be carried out, involving hypertensive participants with dyslipidemia for two months.
Epistemonikos ID: 094196b97a662e4044a04fbe4118a680e3289ce0
First added on: May 15, 2024